Kybernin P 500

Kybernin P 500 is a medicine authorised by Swissmedic under authorisation number 46928. The authorisation holder is CSL Behring AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 November 1994 and the authorisation is valid without a time limit. ATC code B01AB02 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 46928
  • ATC B01AB02
  • Blood products
Authorisation data
Authorisation number46928
NameKybernin P 500
Full nameKybernin P 500, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Authorisation holderCSL Behring AG
Medicinal product codeBlood products
Dispensing categoryB · Prescription only
ATC codeB01AB02
First authorisation24 November 1994
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Kybernin P 500, Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungB24 November 1994
2Kybernin P 1000, Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungB24 November 1994

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1500I.E.B01AB0206.01.1.B
21000I.E.B01AB0206.01.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Kybernin P 500 authorised in Switzerland?

Yes. Kybernin P 500 is authorised by Swissmedic under authorisation number 46928, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Kybernin P 500 have?

Kybernin P 500 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Kybernin P 500?

The authorisation holder is CSL Behring AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com